Skip to content
Sign in

BGMS · NASDAQ

Bio Green Med Solution (BGMS) Stock Price & Fundamentals

$1,502.21−0.57%−$8.60End-of-day price as of Oct 9, 2026

Bio Green Med Solution (BGMS) closed at $1,502.21 on Oct 9, 2026, down 0.57% from the previous close of $1,510.81.

Share price, past year

1Y +33.39%

52-week range $1,118.08 – $1,582.68. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$1,502.21
Sep 30, 2026$1,475.50
Aug 31, 2026$1,536.89
Jul 31, 2026$1,472.24
Jun 30, 2026$1,473.36
May 29, 2026$1,413.64
Apr 30, 2026$1,304.42
Mar 31, 2026$1,372.67
Feb 27, 2026$1,324.33
Jan 30, 2026$1,322.08
Dec 31, 2025$1,263.22
Nov 28, 2025$1,244.42
Oct 31, 2025$1,146.28

Key statistics

Market cap
$9.95B
P/E (TTM)
—
EPS (TTM)
−$6.45
Revenue (TTM)
—
Net income (TTM)
−$2.20M
Shares outstanding
6.6M
Dividend yield
—
52-week range
$1,118.08 – $1,582.68

Bio Green Med Solution's market cap is $9.95B, based on a share price of $1,502.21 and 6.6M shares outstanding as of Jun 30, 2026.

Financials

Bio Green Med Solution reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.

Bio Green Med Solution reported a net loss of $3.00M in fiscal 2025.

Annual revenue

FY15FY16FY17FY18FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Bio Green Med Solution annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$0.00−100.0%−$3.00M—−$6.45—
FY2024ended Dec 31, 2024$43.00K−89.8%−$11.21M−26,074.4%−$502.46—
FY2023ended Dec 31, 2023$420.00K—−$22.56M−5,370.2%−$6,419.18−$16.12M
FY2022ended Dec 31, 2022$0.00—−$21.20M—−$406.57−$20.83M
FY2021ended Dec 31, 2021$0.00—−$18.46M—−$31.19−$18.57M
FY2020ended Dec 31, 2020$0.00−100.0%−$8.45M—−$51.04−$8.03M
FY2018ended Dec 31, 2018$150.00K—−$7.29M−4,858.7%−$9.25−$6.74M
FY2017ended Dec 31, 2017$0.00−100.0%−$7.47M—−$29.10−$7.49M
FY2016ended Dec 31, 2016$843.00K−56.6%−$11.79M−1,398.7%−$52.24—
FY2015ended Dec 31, 2015$1.94M—————
Bio Green Med Solution quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$336.00K−$405.00K—
Q1 FY2026ended Mar 31, 2026$743.00K−$197.00K—
Q3 FY2025ended Sep 30, 2025$81.00K−$988.00K−$1.31
Q4 FY2024ended Dec 31, 2024$0.00−$3.05M−$284.21
Q3 FY2024ended Sep 30, 2024$10.00K−$1.96M−$43.80
Q2 FY2024ended Jun 30, 2024$4.00K—−$172.18
Q1 FY2024ended Mar 31, 2024$29.00K—−$2.27
Q4 FY2023ended Dec 31, 2023$31.00K——

Company profile

Name
Bio Green Med Solution, Inc.
Ticker
BGMS
Exchange
NASDAQ
Industry (SEC SIC)
Wholesale-Durable Goods, NEC
Headquarters
200 Connell Drive, Suite 1500, Berkeley Heights, NJ 07922
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001130166

Recent SEC filings

Frequently asked questions

What is Bio Green Med Solution's stock price?

Bio Green Med Solution (BGMS) closed at $1,502.21 on Oct 9, 2026, down 0.57% from the previous close of $1,510.81.

What is Bio Green Med Solution's market cap?

Bio Green Med Solution's market cap is $9.95B, based on a share price of $1,502.21 and 6.6M shares outstanding as of Jun 30, 2026.

How much revenue does Bio Green Med Solution make?

Bio Green Med Solution reported revenue of $0.00 for fiscal 2025, down 100.00% from fiscal 2024.

Does Bio Green Med Solution pay a dividend?

Bio Green Med Solution's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Bio Green Med Solution, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures